Adempas junior 0.15 mg/ml
Adempas junior 0.15 mg/ml is a medicine authorised by Swissmedic under authorisation number 69929. The authorisation holder is Bayer (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 04 November 2025 and the authorisation is limited until 03 November 2030. ATC code C02KX05 places the medicine in the group Antihypertensives.
| Authorisation number | 69929 |
|---|---|
| Name | Adempas junior 0.15 mg/ml |
| Full name | Adempas junior 0.15 mg/ml, Granulat zur Herstellung einer Suspension zum Einnehmen |
| Authorisation holder | Bayer (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C02KX05 |
| First authorisation | 04 November 2025 |
| Authorisation validity | 03 November 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Adempas junior 0.15 mg/ml, Granulat zur Herstellung einer Suspension zum Einnehmen | B | 04 November 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Flasche(n) | C02KX05 | 02.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Adempas junior 0.15 mg/ml authorised in Switzerland?
Yes. Adempas junior 0.15 mg/ml is authorised by Swissmedic under authorisation number 69929, data as of 01 September 2026. The authorisation is limited until 03 November 2030.
Which dispensing category does Adempas junior 0.15 mg/ml have?
Adempas junior 0.15 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Adempas junior 0.15 mg/ml?
The authorisation holder is Bayer (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.